These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 3115287)
41. Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Dechant KL; Goa KL Drugs; 1991 Feb; 41(2):202-24. PubMed ID: 1709851 [TBL] [Abstract][Full Text] [Related]
42. Acute asthma attack caused by ophthalmic application of antiallergic agents. Uchio E; Kadonosono K Jpn J Ophthalmol; 2004; 48(5):475-7. PubMed ID: 15486771 [TBL] [Abstract][Full Text] [Related]
43. Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin. Nathan H; Naveh N; Meyer E Doc Ophthalmol; 1994; 85(3):247-57. PubMed ID: 7924852 [TBL] [Abstract][Full Text] [Related]
44. Double-blind trial of pentigetide ophthalmic solution, 0.5%, compared with cromolyn sodium, 4%, ophthalmic solution for allergic conjunctivitis. Kalpaxis JG; Thayer TO Ann Allergy; 1991 May; 66(5):393-8. PubMed ID: 1903616 [TBL] [Abstract][Full Text] [Related]
45. Clinical trial of the topical use of disodium cromoglycate in vernal, allergic and chronic conjunctivitis. Leino M; Tuovinen E Acta Ophthalmol (Copenh); 1980; 58(1):121-4. PubMed ID: 6773293 [TBL] [Abstract][Full Text] [Related]
46. Local specific immunotherapy in allergic conjunctivitis. Del Prete A; Loffredo C; Carderopoli A; Caparello O; Verde R; Sebastiani A Acta Ophthalmol (Copenh); 1994 Oct; 72(5):631-4. PubMed ID: 7887165 [TBL] [Abstract][Full Text] [Related]
52. The effect of sodium cromoglycate eyedrops compared to the effect of terfenadine on acute symptoms of seasonal allergic conjunctivitis. Leino M; Carlson C; Kilkku O; Kumpulainen T; Kyrönpalo-Kauppinen S; Laaka V; Norio M; Valtola J Acta Ophthalmol (Copenh); 1992 Jun; 70(3):341-5. PubMed ID: 1636394 [TBL] [Abstract][Full Text] [Related]
53. [Effects levocabastine ophthalmic solution (H1 receptor antagonist) on symptoms of vernal conjunctivitis. A prospective, randomized double-blind study]. Graue E Gac Med Mex; 1994; 130(6):481-6. PubMed ID: 7557064 [TBL] [Abstract][Full Text] [Related]
54. Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice. Shii D; Oda T; Shinomiya K; Katsuta O; Nakamura M J Ocul Pharmacol Ther; 2009 Aug; 25(4):321-8. PubMed ID: 19650707 [TBL] [Abstract][Full Text] [Related]
55. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Ozcan AA; Ersoz TR; Dulger E Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529 [TBL] [Abstract][Full Text] [Related]
56. Cromolyn effects on vernal keratoconjunctivitis in children. Tabbara KF; Arafat NT Arch Ophthalmol; 1977 Dec; 95(12):2184-6. PubMed ID: 412489 [TBL] [Abstract][Full Text] [Related]
57. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
58. Lodoxamide in vernal keratoconjunctivitis. Lee S; Allard TR Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338 [TBL] [Abstract][Full Text] [Related]
59. Hyposensitization in the treatment of resistant cases of vernal keratoconjunctivitis. Mahdy RA; Nada WM; Shahien EA; Boghdadi GA; Marei AA Cutan Ocul Toxicol; 2010 Sep; 29(3):198-202. PubMed ID: 20670088 [TBL] [Abstract][Full Text] [Related]